Our growing awareness of the microbial world’s importance and diversity contrasts starkly with our limited understanding of its fundamental structure.

Due to its fundamental role in the induction, training, and function of the immune system, it is critical to include characterizations of the gut microbiome in clinical trials and studies that aim to broaden our understanding of coronavirus disease 2019 (COVID-19).

Environmental factors, mucosal permeability and defective immunoregulation drive over- active immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions.

The Microbiome as a source of new enterprises and job creation: Considering clinical faecal and synthetic microbiome transplants and therapeutic regulation.